Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- PP-H6939-00 - Provider product page
- Provider
- R&D Systems
- Product name
- Human HNF-4 alpha/NR2A1 Antibody
- Antibody type
- Monoclonal
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- H6939
- Vial size
- 100 ug
- Storage
- Store the unopened product at -70 °C. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Do not use past expiration date.
Submitted references Ferroptosis is governed by differential regulation of transcription in liver cancer.
Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity.
TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors.
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.
Novel P2 promoter-derived HNF4alpha isoforms with different N-terminus generated by alternate exon insertion.
Novel P2 promoter-derived HNF4alpha isoforms with different N-terminus generated by alternate exon insertion.
Zhang X, Du L, Qiao Y, Zhang X, Zheng W, Wu Q, Chen Y, Zhu G, Liu Y, Bian Z, Guo S, Yang Y, Ma L, Yu Y, Pan Q, Sun F, Wang J
Redox biology 2019 Jun;24:101211
Redox biology 2019 Jun;24:101211
Developmental History Provides a Roadmap for the Emergence of Tumor Plasticity.
Tata PR, Chow RD, Saladi SV, Tata A, Konkimalla A, Bara A, Montoro D, Hariri LP, Shih AR, Mino-Kenudson M, Mou H, Kimura S, Ellisen LW, Rajagopal J
Developmental cell 2018 Mar 26;44(6):679-693.e5
Developmental cell 2018 Mar 26;44(6):679-693.e5
TET-Catalyzed 5-Hydroxymethylation Precedes HNF4A Promoter Choice during Differentiation of Bipotent Liver Progenitors.
Ancey PB, Ecsedi S, Lambert MP, Talukdar FR, Cros MP, Glaise D, Narvaez DM, Chauvet V, Herceg Z, Corlu A, Hernandez-Vargas H
Stem cell reports 2017 Jul 11;9(1):264-278
Stem cell reports 2017 Jul 11;9(1):264-278
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.
Saha SK, Parachoniak CA, Ghanta KS, Fitamant J, Ross KN, Najem MS, Gurumurthy S, Akbay EA, Sia D, Cornella H, Miltiadous O, Walesky C, Deshpande V, Zhu AX, Hezel AF, Yen KE, Straley KS, Travins J, Popovici-Muller J, Gliser C, Ferrone CR, Apte U, Llovet JM, Wong KK, Ramaswamy S, Bardeesy N
Nature 2014 Sep 4;513(7516):110-4
Nature 2014 Sep 4;513(7516):110-4
Novel P2 promoter-derived HNF4alpha isoforms with different N-terminus generated by alternate exon insertion.
Huang J, Levitsky LL, Rhoads DB
Experimental cell research 2009 Apr 15;315(7):1200-11
Experimental cell research 2009 Apr 15;315(7):1200-11
Novel P2 promoter-derived HNF4alpha isoforms with different N-terminus generated by alternate exon insertion.
Huang J, Levitsky LL, Rhoads DB
Experimental cell research 2009 Apr 15;315(7):1200-11
Experimental cell research 2009 Apr 15;315(7):1200-11
No comments: Submit comment
No validations: Submit validation data